U.S. Markets closed

Global Regenerative Medicine (Cell Therapy, Tissue Engineering, Gene Therapy) Market Outlook 2025 - Adoption of 3D Bioprinting & Use of Nanomaterial for Tissue Regeneration - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--

The "Global Regenerative Medicine Market - By Technology (Cell Therapy, Tissue Engineering, Gene Therapy), Region (North America [US], Europe [UK], Asia Pacific [Japan]) Market Outlook 2025" report has been added to ResearchAndMarkets.com's offering.

Utilization of nanomaterial for tissue generation has created avenues for a new realm of advancement in the field of regenerative medicine. It has facilitated control of biochemical and mechanical microenvironment for successful cell delivery and tissue regeneration especially in wound care, drug delivery, and immunomodulation.

The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market-specific growth opportunities in the global regenerative medicine market. The report has been segmented as follows:-

Key Vendors

  • Integra LifeSciences Corporation
  • Merck & Co., Inc.
  • Stryker Corporation
  • Organogenesis Inc.
  • Vericell Corporation
  • MiMedx Group

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Regenerative Medicine

3.1 Overview

3.1.1 Mechanism of Action

3.2 Therapies

3.2.1 Cell Therapy

3.2.2 Tissue Engineering

3.2.3 Gene Therapy

3.2.4 Small Molecule

4. Market Analysis

4.1 Market Sizing (Actual & Forecasted)

4.2 Market Share Analysis

4.2.1 Market Share by Therapy

4.2.2 Market Share by Material

4.2.3 Market Share by Therapeutic Application

4.2.4 Market Share by End-User

4.2.5 Market Share by Region

5. Market Segmentation

5.1 Cell Therapy

5.1.1 Market Sizing (Actual & Forecasted)

5.1.2 Market Share by Region

5.2 Tissue Engineering

5.3 Gene Therapy

6. Regional Analysis

6.1 North America

6.1.1 Market Sizing (Actual &Forecasted)

6.1.2 The US

6.1.2.1 Market Sizing (Actual & Forecasted)

6.1.2.1 Market Share by End-User

6.2 Europe

6.3 Asia Pacific

7. Market Dynamics

7.1 Industry Trends & Developments

7.1.1 Dominance of Dermatology Segment

7.1.2 Adoption of 3D Bioprinting

7.1.3 Use of Nanomaterial for Tissue Regeneration

7.1.4 Higher Investments in Niche Therapies

7.2 Growth Drivers

7.2.1 Prevalence of Chronic Diseases

7.2.2 Rise in Number of Trauma Cases

7.2.3 Organ Shortages

7.2.4 Increasing Incidence of Cancer

7.2.5 Growing Geriatric Population

7.2.6 Increasing R&D Investment

7.3 Challenges

7.3.1 Expensive Treatment Cost

7.3.2 Stringent Regulatory Compliance

8. Competitive Landscape

8.1 Financial Analysis

8.2 Market Share Analysis

9. Company Profiles

9.1 Integra LifeSciences Corporation

9.2 Merck & Co., Inc.

9.3 Stryker Corporation

9.4 Organogenesis Inc.

9.5 Vericell Corporation

9.6 MiMedx Group, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/dim9k8

View source version on businesswire.com: https://www.businesswire.com/news/home/20190711005368/en/